Effects of long-term estrogen replacement therapy versus combined hormone replacement therapy on nitric oxide-dependent vasomotor function

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4348-4354

  Jokela, Hannu ^a   Dastidar, Prasun ^a   Rontu, Riikka ^a,b   Salomäki, Anne ^a   Teisala, Klaus ^a   Lehtimaki, Terho ^a,b   Punnonen, Reijo ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL VALERATE; ESTROGEN; LEVONORGESTREL; NITRATE; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA;

ABDOMINAL AORTA; ADULT; ARTICLE; CIRCULATION; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ECHOGRAPHY; ENDOTHELIUM; ESTROGEN THERAPY; FEMALE; HUMAN; IN VIVO STUDY; INTERNAL CAROTID ARTERY; LIPID PEROXIDATION; MENOPAUSAL SYNDROME; MOLECULAR INTERACTION; PLASMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; URINARY EXCRETION; VASOMOTOR REFLEX;

AGED; AORTA, ABDOMINAL; CAROTID ARTERIES; CHOLESTEROL, HDL; DINOPROST; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; LEVONORGESTREL; LIPID PEROXIDATION; LIPIDS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE;

EID: 0141453022     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030029     Document Type: Article

References (53)

1. Barrett-Connor E, Bush TL 1991 Estrogen and coronary heart disease in women. JAMA 265:1861-1867
2. Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE 1981 Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1:858-860
3. Austin CE 2000 Chronic and acute effects of oestrogens on vascular contractility. J Hypertens 18:1365-1378
4. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
5. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA 1994 Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 121:936-941
6. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA 1995 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 92:24-30
7. Sanada M, Higashi Y, Nakagawa K, Tsuda M, Kodama I, Kimura M, Chayama K, Ohama K 2002 Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab 87:4634-4641
8. Ganz P 2002 Vasomotor and vascular effects of hormone replacement therapy. Am J Cardiol 90:11F-16F
9. Sugioka K, Shimosegawa Y, Nakano M 1987 Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 210:37-39
10. Napoli C, Lerman LO, de Nigris F, Loscalzo J, Ignarro LJ 2002 Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells. J Am Coll Cardiol 40:1515-1522
11. Mehta JL, Bryant JL, Jr, Mehta P 1995 Reduction of nitric oxide synthase activity in human neutrophils by oxidized low-density lipoproteins. Reversal of the effect of oxidized low-density lipoproteins by high-density lipoproteins and L-arginine. Biochem Pharmacol 50:1181-1185
12. Chen LY, Mehta P, Mehta JL 1996 Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function. Circulation 93:1740-1746
13. Tanner FC, Noll G, Boulanger CM, Luscher TF 1991 Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 83:2012-2020
14. Raitakari OT, Pitkanen OP, Lehtimaki T, Lahdenpera S, Iida H, Yla-Herttuala S, Luoma J, Mattila K, Nikkari T, Taskinen MR, Viikari JS, Knuuti J 1997 In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. J Am Coll Cardiol 30:97-102
15. Ross R 1999 Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
16. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ 2000 A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 133:933-941
17. Stampfer MJ, Colditz GA 1991 Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:47-63
18. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:605-613
19. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N 2002 Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA 288:49-57
20. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI 2001 A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 345:1243.1249
21. Sorensen KE, Dorup I, Hermann AP, Mosekilde L 1998 Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 97:1234-1238
22. Yim SF, Lau TK, Sahota DS, Chung TK, Chang AM, Haines CJ 1998 Prospective randomized study of the effect of "add-back" hormone replacement on vascular function during treatment with gonadotropin-releasing hormone agonists. Circulation 98:1631-1635
23. Kawano H, Motoyama T, Hirai N, Yoshimura T, Kugiyama K, Ogawa H, Okamura H, Yasue H 2001 Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women. Am J Cardiol 87:238A9-240A9
24. Koh KK, Jin DK, Yang SH, Lee SK, Hwang HY, Kang MH, Kim W, Kim DS, Choi IS, Shin EK 2001 Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation 103:1961-1966
25. Gambacciani M, Monteleone P, Vitale C, Silvestri A, Fini M, Genazzani AR, Rosano GM 2002 Dydrogesterone does not reverse the effects of estradiol on endothelium-dependent vasodilation in postmenopausal women: a randomised clinical trial. Maturitas 43:117
26. Miller VM, Vanhoutte PM 1991 Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 261:1022R-1027R
27. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387
28. Nquven T, Warnig R 1989 Improved method for separation of total HDL cholesterol and subclasses. Clin Chem 35:1086
29. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultrasentrifuge. Clin Chem 18:499-502
30. Leone AM, Francis PL, Rhodes P, Moncada S 1994 A rapid and simple method for the measurement of nitrite and nitrate in plasma by high performance capillary electrophoresis. Biochem Biophys Res Commun 200:951-957
31. Gosling KF, Beasly MG, Lewis RR 1982 Non-invasive demonstration of disease at the carotid bifurcation by ultrasound. In: Reneman RS, Hoeks APG, eds. Doppler ultrasound in the diagnosis of cerebrovascular disease. New York: Research Studies Press; 215-253
32. Pines A, Fisman EZ, Levo Y, Averbuch M, Lidor A, Drory Y, Finkelstein A, Hetman-Peri M, Moshkowitz M, Ben-Ari E 1991 The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow. Am J Obstet Gynecol 164:806-812
33. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH 1996 Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335:453-461
34. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM 1987 Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75:1102-1109
35. Lobo RA, Notelovitz M, Bernstein L, Khan FY, Ross RK, Paul WL 1992 Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen. Am J Obstet Gynecol 166:1182-1188
36. Farish E, Rolton HA, Barnes JF, Hart DM 1991 Lipoprotein(a) concentrations in postmenopausal women taking norethisterone. Br Med J 303:694
37. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S 1991 Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 338:839-842
38. Imthurn B, Rosselli M, Jaeger AW, Keller PJ, Dubey RK 1997 Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. J Clin Endocrinol Metab 82:388-394
39. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL 1989 Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924
40. Sack MN, Rader DJ, Cannon III RO 1994 Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343:269-270
41. Guetta V, Panza JA, Waclawiw MA, Cannon III RO 1995 Effect of combined 17β-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women. Am J Cardiol 75:1274-1276
42. McManus J, McEneny J, Thompson W, Young IS 1997 The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. Atherosclerosis 135:73-81
43. Wakatsuki A, Ikenoue N, Sagara Y 1998 Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women. Maturitas 28:229-234
44. Koh KK, Mincemoyer R, Bui MN, Csako G, Pucino F, Guetta V, Waclawiw M, Cannon III RO 1997 Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med 336:683-690
45. Koivu TA, Dastidar P, Jokela H, Nikkari ST, Jaakkola O, Koivula T, Punnonen R, Lehtimaki T 2001 The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women. Atherosclerosis 157:471-479
46. Morrow JD, Frei B, Longmire AW, Caziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJI 1995 Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 332:1198-1203
47. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJI 1992 Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89:10721-10725
48. Catella F, Reilly MP, Delanty N, Lawson JA, Moran N, Meagher E, FitzGerald GA 1995 Physiological formation of 8-epi-PGF2α in vivo is not affected by cyclooxygenase inhibition. Adv Prostaglandin Tromboxane Leukotriene Res 23:233-236
49. Behr-Roussel D, Rupin A, Simonet S, Fabiani J, Verbeuren TJ 2000 Urinary nitrate excretion in cholesterol-fed rabbits: effect of a chronic treatment by N-iminoethyl-L-lysine, a selective inhibitor of inducible nitric oxide synthase. Eur J Pharmacol 388:275-279
50. Baylis C, Vallance P 1998 Measurement of nitrite and nitrate levels in plasma and urine-what does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 7:59-62
51. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA 1990 Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624
52. Alfon J, Guasch JF, Berrozpe M, Badimon L 1999 Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors. Atherosclerosis 145:325-331
53. Behr-Roussel D, Rupin A, Sansilvestri-Morel P, Fabiani JN, Verbeuren TJ 2000 Histochemical evidence for inducible nitric oxide synthase in advanced but non-ruptured human atherosclerotic carotid arteries. Histochem J 32:41-51